Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Millions.
The item "Sale-Or-Purchase-of-Stock" stands at -4.00 Million Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2013.
Chugai Pharmaceutical Co. Ltd.'s third quarter result of -1.00 Million JPY for the item "Sale Or Purchase of Stock" represents no change compared to it's second quarter result.
Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of -1.00 Million JPY for the item "Sale Or Purchase of Stock" represents an increase of 75.00 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of -4.00 Million JPY for the item "Sale Or Purchase of Stock" represents an increase of 42.86 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.00 Million Japanese Yens compared to the value the year prior.
The 1 year change is 7.00 Million Japanese Yens.
The 3 year change is 1.00 Million Japanese Yens.
The 5 year change is 33.00 Million Japanese Yens.
The 10 year change is 15.00 Million Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Sale Or Purchase of Stock | 905,699,262,464.00 |
![]() | Johnson & Johnson - Sale Or Purchase of Stock | 486,508,953,600.00 |
![]() | AbbVie Inc - Sale Or Purchase of Stock | 399,570,305,024.00 |
![]() | Roche Holding AG - Sale Or Purchase of Stock | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Sale Or Purchase of Stock | 280,205,508,085.11 |